Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinsons Disease. Front Neurol. 2018 Oct 15;9:860. doi: 10.3389/fneur.2018.00860. eCollection 2018. Review. PMID: 30459700 Free PMC Article


Neuroinflammation is one of the most important processes involved in the pathogenesis of Parkinsons disease (PD). The current concept of neuroinflammation comprises an inflammation process, which occurs in the central nervous system due to molecules released from brain-resident and/or blood-derived immune cells. Furthermore, the evidence of the contribution of systemic delivered molecules to the disease pathogenesis, such as the gut microbiota composition, has been increasing during the last years. Under physiological conditions, microglia and astrocytes support the well-being and well-function of the brain through diverse functions, including neurotrophic factor secretion in both intact and injured brain. On the other hand, genes that cause PD are expressed in astrocytes and microglia, shifting their neuroprotective role to a pathogenic one, contributing to disease onset and progression. In addition, growth factors are a subset of molecules that promote cellular survival, differentiation and maturation, which are critical signaling factors promoting the communication between cells, including neurons and blood-derived immune cells. We summarize the potential targeting of astrocytes and microglia and the systemic contribution of the gut microbiota in neuroinflammation process archived in PD.

Troncoso-Escudero P, Parra A, Nassif M, Vidal RL.

Frontiers In Neurology (Front Neurol.)

octubre 15, 2018

DOI: 10.3389/fneur.2018.00860

Investigador BNI: René Vidal